Pharmacytimes: Condition Center: HIV HIV en-us Mon, 23 Jan 2017 12:39:20 UTC Mon, 23 Jan 2017 12:39:20 UTC ART in HIV: Start Today In HIV treatment, national and global guidelines recommend initiating antiretroviral therapy (ART) in all patients, regardless of CD4 count.&nbsp; 2:29 PM, Tue January 10, 2017 Counsel PrEP and ART Strategies in HIV-Serodiscordant Couples Experts agree that integrated antiretroviral therapy (ART) for HIV-positive partners and time-limited pre-exposure prophylaxis (PrEP) for negative partners almost eliminates HIV transmission.&nbsp; 11:43 AM, Thu December 29, 2016 5 Studies That Shaped HIV Treatment That Every Pharmacist Should Know Over the years, a number of landmark clinical studies in the field of virology have been published, shaping how we treat many infectious diseases today 9:43 PM, Tue December 27, 2016 The HIV Epidemic: Is Increased Access to Syringe Services the Answer? Syringe services programs (SSPs) aim to reduce the spread of HIV among people who inject drugs (PWID), as use of shared needles puts them at high risk of contracting or transmitting the infection.&nbsp; 6:00 AM, Wed December 21, 2016 Opportunistic Infections: Better Have a Pharmacist Onboard Approximately 1.2 million individuals live with HIV/AIDS in the United States. This population is at an increased risk of opportunistic infections (OIs), an area where pharmacists have significant potential to make meaningful interventions.&nbsp; 10:56 AM, Mon December 19, 2016 A Shift In Thinking on When to Initiate Antiretroviral Therapy The recommended time to begin antiretroviral therapy (called the ART-start threshold) has changed since ART first arrived in the mid 90s. Now, clinicians are able to prescribe ART more liberally because of its improved adverse event profile and wider array of available drugs. 12:49 PM, Thu December 15, 2016 These Treatments Improve PHT in Patients With HIV and HCV Patients who have human immunodeficiency virus (HIV) infection are at elevated risk for HCV. 3:04 PM, Tue December 13, 2016 WATCH: WHO Guide to Testing Options for HIV In this week&#39;s &quot;Around the Web,&quot; <em>Pharmacy Times</em> presents a video that was recently posted by the World Health Organization, which discusses self-testing options for HIV. 11:10 AM, Fri December 2, 2016 Collaborative Care for HIV Patients with Depression Individuals living with HIV have approximately a 50-50 chance of developing depression, which can cause adverse outcomes such as accelerated disease progression, suppressed immune function, and medication nonadherence. 8:00 AM, Wed November 30, 2016 New HIV Vaccine Study Underway in South Africa A historic clinical trial testing the efficacy of an experimental HIV vaccine regimen gets underway this week in South Africa. 2:16 PM, Tue November 29, 2016 Drug Interactions Are Biggest Barrier in Patients With HIV and Cancer Much research and literature has been devoted to cardiovascular diseases, neurocognitive diseases, and neuroendocrine dysfunction in the aging patient with HIV, but cancer in patients with HIV is also a growing concern. 1:17 PM, Mon November 21, 2016 HAART: What's Best in Treatment-Naive HIV Patients? With the many agents available for highly active antiretroviral therapy (HAART), selecting the best regimen in HAART-na&iuml;ve patients is not an easy task.<br /> &nbsp; 12:06 PM, Tue November 8, 2016 Target and Tailor Interventions for HIV HIV has been an epidemic for 30 years. Initially, the health system relied on behavioral interventions to slow the spread of the virus. 8:58 AM, Thu November 3, 2016 Using Monoclonal Antibody Therapy to Fight HIV Infection Successful highly active antiretroviral therapy (HAART) has allowed the long-term effects of HIV infection and chronic medication toxicity to become the primary cause of death and disability. However, HIV-positive patients are at greater risk for cardiovascular disease and cancers due to excessive inflammation, and HAART does not eliminate HIV-related inflammation even if the patient adheres to treatment perfectly. 2:48 AM, Thu October 20, 2016 Why HIV Infection Prolongs QTc Interval HIV-positive patients experience sudden death more often than the general population, but scant evidence connects HIV severity and highly active antiretroviral therapy regimens. 8:00 AM, Thu October 13, 2016 Choosing the Best Contraceptive for Adolescents with HIV Adolescents underestimate their risk of contracting HIV, and 60% of infected patients are unaware of their status. 8:00 AM, Tue October 11, 2016 How HIV Affects Ocular Syphilis Outcomes The number of syphilis cases has risen steadily in the United States since 2000. Those who are at particularly elevated risk include men who have sex with men and patients infected with human immunodeficiency virus (HIV). 8:00 AM, Thu October 6, 2016 HIV and Low Vitamin D: A Look at Mechanisms HIV and tuberculosis (TB) have both been associated with low vitamin D levels, and so has treatment with efavirenz. 8:00 AM, Wed September 28, 2016 HIV PrEP Presents a Pharmacist Counseling Opportunity Science and solid research has made us aware of exactly who is at high risk for HIV exposure, and the health care community has done a remarkable job warning at-risk populations and recommending preventive measures. 9:00 PM, Mon September 19, 2016 Best HIV Intervention: Test-and-Treat, PrEP, or Both? In the United States, new HIV infections occur most often among men who have sex with men (MSM), African Americans, and adults aged 30 to 64 years. 9:39 PM, Thu September 15, 2016